Abstract
Accurate and prompt prediction of outcome after stroke is essential for patients, their families, and clinicians. The authors validated the incremental prognostic value of copeptin—a stress biomarker—over existing clinical prediction models. Copeptin may help in early decision making for intensity of monitoring, interventions, and discharge planning. See p. 1278; Editorial, p. 1270 The authors identified large-artery atherosclerosis as a major risk factor in younger ischemic stroke patients (18-55 years old). The prevalence of extracranial carotid artery stenoses and occlusions was 8.9%, of which …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
